Mary Shomon has an interview with Dr. Richard Shames MD concerning the new ATA Guidelines. It is a good read. PR
"First, I am distressed that an organization that gets substantial funding from levothyroxine manufacturers can publish over 200 pages of medical-ese, mainly intended to browbeat every doctor in the country into treating a complex, chronic, autoimmune, hormonal illness like hypothyroidism with simple levothyroxine alone. It's a bit like Washington, DC's "K-Street tactics," where the government regulators writing the rules are former and future industry employees."